Physician profile
Sarah E Baker
NPI 1134482706
$16,893.00
in general payments reported to CMS, 2019-2025
15 companies · $287 in 2025
The $287 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,776 · 2020: $38.17 · 2021: $121 · 2022: $3,065 · 2023: $8,178 · 2024: $3,429 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,150 · Travel and Lodging: $3,011 · Food and Beverage: $1,717 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,150.00 |
| Travel and Lodging | $3,010.50 |
| Food and Beverage | $1,716.84 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,580.20 | 2022-2024 | Da Vinci Surgical System, Davinci Xi |
| Becton, Dickinson and Company | $1,719.21 | 2023-2024 | Phasix Mesh |
| Edwards Lifesciences Corporation | $1,631.55 | 2019 | |
| Davol INC. | $287.90 | 2023-2025 | Arista Ah Flexitip, Channel Drain, Phasix Mesh |
| Baxter Healthcare | $142.24 | 2021-2025 | Tisseel |
| E.R. Squibb & Sons, L.L.C. | $101.22 | 2022 | |
| Astellas Pharma US INC | $99.00 | 2019 | |
| Abbvie INC. | $85.14 | 2025 | |
| Glaxosmithkline, LLC. | $83.23 | 2019-2020 | |
| Dilon Technologies, INC. | $38.90 | 2025 | Hemoblast Bellows |
| Pacira Pharmaceuticals Incorporated | $36.74 | 2025 | Exparel |
| Vertex Pharmaceuticals Incorporated | $32.55 | 2025 | |
| Alcresta Therapeutics, INC. | $19.68 | 2025 | Relizorb |
| Axonics, INC. | $17.81 | 2023 | Axonics |
| Celltrion USA INC. | $17.63 | 2025 | Vegzelma |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.